EATRIS
The European Advanced Translational Research Infrastructure in Medicine
| Coordinatore | HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
Organization address
address: Inhoffenstrasse 7 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 5˙475˙996 € |
| EC contributo | 4˙200˙000 € |
| Programma | FP7-INFRASTRUCTURES
Specific Programme "Capacities": Research infrastructures |
| Code Call | FP7-INFRASTRUCTURES-2007-1 |
| Funding Scheme | CP-CSA-Infra |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-01-01 - 2010-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
Organization address
address: Inhoffenstrasse 7 contact info |
DE (BRAUNSCHWEIG) | coordinator | 0.00 |
| 2 |
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
Organization address
address: Heinemannstrasse 2 contact info |
DE (BONN) | participant | 0.00 |
| 3 |
CENTER FOR TRANSLATIONAL MOLECULAR MEDICINE CTMM
Organization address
address: High tech Campus 11 contact info |
NL (EINDHOVEN) | participant | 0.00 |
| 4 |
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Organization address
address: RUE LEBLANC 25 contact info |
FR (PARIS 15) | participant | 0.00 |
| 5 |
DEUTSCHES KREBSFORSCHUNGSZENTRUM
Organization address
address: Im Neuenheimer Feld 280 contact info |
DE (HEIDELBERG) | participant | 0.00 |
| 6 |
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIVERSITARI VALL D'HEBRON
Organization address
address: Passeig Vall d'Hebron contact info |
ES (BARCELONA) | participant | 0.00 |
| 7 |
HELSINGIN YLIOPISTO
Organization address
address: YLIOPISTONKATU 4 contact info |
FI (HELSINGIN YLIOPISTO) | participant | 0.00 |
| 8 |
HERMANN VON HELMHOLTZ-GEMEINSCHAFT DEUTSCHER FORSCHUNGSZENTRUM EV
Organization address
address: Ahrstrasse 45 contact info |
DE (BONN) | participant | 0.00 |
| 9 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 0.00 |
| 10 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 0.00 |
| 11 |
ISTITUTO SUPERIORE DI SANITA
Organization address
address: Viale Regina Elena 299 contact info |
IT (ROMA) | participant | 0.00 |
| 12 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 0.00 |
| 13 | KOBENHAVNS UNIVERSITET | DK | participant | 0.00 |
| 14 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 0.00 |
| 15 |
MINISTERO DELLA SALUTE
Organization address
address: Via Giorgio Ribotta 5 contact info |
IT (ROMA) | participant | 0.00 |
| 16 |
NIEDERSAECHSISCHES MINISTERIUM FUER WISSENSCHAFT UND KULTUR
Organization address
address: Leibnizufer 9 contact info |
DE (HANNOVER) | participant | 0.00 |
| 17 |
STOCKHOLMS LAENS LANDSTING
Organization address
address: Hantverkargatan 45 contact info |
SE (STOCKHOLM) | participant | 0.00 |
| 18 |
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
NL (DEN HAAG) | participant | 0.00 |
| 19 |
UNIVERSITETET I OSLO
Organization address
address: Problemveien 5-7 contact info |
NO (OSLO) | participant | 0.00 |
| 20 |
VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL
Organization address
address: VASTRA JARNVAGSGATAN 3 contact info |
SE (STOCKHOLM) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Efficient translation of research discoveries into industrial application is an essential element to maintain Europe’s competitiveness in the biomedical and health industry. The main bottleneck is the lack and the fragmented nature of essential research infrastructure and know-how, leading to unacceptable delays and/or preventing the development of new innovative medicines. The aim of EATRIS is to fill this gap by developing a European Advanced Translation Research InfraStructure consisting of key preclinical and clinical components necessary to support the development of new diagnostic or therapeutic strategies at all stages of the biomedical R&D-process. EATRIS will operate through a network of biomedical translation research centres across Europe which will provide user access to: • State of the art animal facilities for preclinical proof of principle and proof of concept studies • Small molecule screening facilities to identify and characterize new drug targets • High-resolution imaging facilities for preclinical and clinical validation • Disease-specific patient and population cohorts to develop and validate new innovative diagnostic and therapeutic strategies • Centralized GMP facilities for bioprocess development and manufacturing • Facilities for Clinical Phase I studies. During the preparatory phase EATRIS will work out a master plan describing in detail the establishment and mode of operation of the planned pan-European infrastructure during a later construction phase: This will include an agreement on the key legal, governance, strategic and financial issues as well as a concept to train and educate the next generation of biomedical translation researchers. Users of EATRIS will be biomedical researchers and clinical scientists located at universities, research institutions or SME´s that need to use this infrastructure in order to overcome specific bottlenecks and to move their research projects from a discovery to a preclinical and clinical stage.
Introduzione (Teaser)
Establishing a new infrastructure of leading translational research and development facilities will help turn biomedical research into useful therapies. Such an infrastructure will support the development process for drugs and other medical products with an unmet medical need and raise the quality of life for Europeans.